Quick Takeaways
- WESTFIELD CAPITAL MANAGEMENT CO LP filed SCHEDULE 13G/A for Ascendis Pharma A/S Common Stock (ASND).
- Disclosed ownership: 9.2%.
- Date of event: 31 Dec 2024.
WESTFIELD CAPITAL MANAGEMENT CO LP - 31 Dec 2024 SCHEDULE 13G/A Report for Ascendis Pharma A/S Common Stock (ASND)
- Filing Manager
- WESTFIELD CAPITAL MANAGEMENT CO LP
- Reporting Manager
- Westfield Capital Management Company, L.P.
- Security
- Ascendis Pharma A/S Common Stock
- Symbol
- ASND
- Shares outstanding
- 60,220,468 shares
- Disclosed Ownership
- 5,528,239 shares
- Ownership
- 9.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 11 Feb 2025, 09:15:25 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 11 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"WESTFIELD CAPITAL MANAGEMENT CO LP disclosed 9.2% ownership in Ascendis Pharma A/S Common Stock (ASND) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 11 Feb 2025, 09:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Westfield Capital Management Company, L.P. | 9.2% | 5,528,239 | 3,870,550 | 0 | Brandi McMahon | Vice President, Deputy Chief Compliance Officer |